|Articles|February 9, 2022
Retrofit Pharmaceutical Equipment for High Containment and Reduced Risk of Cross Contamination
Author(s)ILC Dover
With the growth of highly potent active pharmaceutical ingredients (HPAPIs) and multiple-use facilities that must protect against product cross contamination, the need for engineering controls to achieve high containment has become more critical.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
PharmTech Weekly Roundup - February 6, 2026
4
Women in STEM: Early Phase Drug Development
5